Hartford Connecticut Financial Company signed a $1.5 billion reinsurance agreement to cover its asbestos and environmental liability exposures. […]
|
||||
Hartford Connecticut Financial Company signed a $1.5 billion reinsurance agreement to cover its asbestos and environmental liability exposures. […] City of Hope cancer center thoracic oncologist Dr. Marianna Koczywas explains the workings of tazemetostat — the latest drug tested in a mesothelioma clinical trial — with the lock and key metaphor. “You have a specific [cancer] key, and a specific keyhole it goes through. If you can lock that keyhole, you can lock it… The post Mesothelioma Clinical Trial for Tazemetostat Launches in US appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families. […] Hartford Connecticut Financial Company’s profits dropped drastically in Q2 due to an asbestos and mesothelioma cases in its property and casualty business. […] An international team of scientists recently identified a new blood biomarker for mesothelioma that should help with early diagnosis, prognosis accuracy and the personalization of treatment. Researchers identified activin A, a protein complex found in the blood, as a potential target for future therapies. “Blood derived biomarkers are important because they can be noninvasively measured,… The post Researchers Discover New Mesothelioma Blood Biomarker appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families. […] An international team of scientists recently identified a new blood biomarker for mesothelioma that should help with early diagnosis, prognosis accuracy and the personalization of treatment. Researchers identified activin A, a protein complex found in the blood, as a potential target for future therapies. “Blood derived biomarkers are important because they can be noninvasively measured,… The post Researchers Discover New Mesothelioma Blood Biomarker appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families. […] An international team of scientists recently identified a new blood biomarker for mesothelioma that should help with early diagnosis, prognosis accuracy and the personalization of treatment. Researchers identified activin A, a protein complex found in the blood, as a potential target for future therapies. “Blood derived biomarkers are important because they can be noninvasively measured,… The post Researchers Discover New Mesothelioma Blood Biomarker appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families. […] Renowned thoracic surgeon Dr. Wickii Vigneswaran in Chicago believes far too many patients with pleural mesothelioma are being denied aggressive surgeries that could improve their quality of life. He wants to fix that dilemma. Vigneswaran, a mesothelioma specialist at the Loyola University Medical Center, authored a recent study debunking the long-standing belief that major surgery… The post Mesothelioma Surgery Improves Quality of Life appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families. […] The Dartmouth College researchers determined that such decisions might be overlooking a person’s chance of experiencing comfort in their dying days. […] Some scientists believe combination therapies such as those used for AIDS patients could eventually cure cancer […] |